Curiously, in in vitro studies, IL-15 combined with TIGIT inhibition has also been found to increase the activity of NK cells’ cytotoxicity versus that of melanoma cells, and to reduce the development of tumor metastasis in mouse melanoma [70] and soft tissue sarcoma models [71]. This evidence concerns the gene TIGIT and melanoma.